Title: Radioimmunotherapy of Cryptococcus neoformans Spares Bystander Mammalian Cells
Authors: BRYAN R. A.JIANG Z.MORGENSTERN AlfredBRUCHERTSEIFER FrankCasadevall ArturoDADACHOVA E.
Citation: FUTURE MICROBIOLOGY vol. 8 no. 9 p. 1081-1089
Publisher: FUTURE MEDICINE LTD
Publication Year: 2013
JRC N°: JRC80499
ISSN: 1746-0913
URI: http://www.futuremedicine.com/doi/abs/10.2217/fmb.13.79
http://publications.jrc.ec.europa.eu/repository/handle/JRC80499
DOI: 10.2217/FMB.13.79
Type: Articles in periodicals and books
Abstract: Background: Previously, we showed that radioimmunotherapy (RIT) for cryptococcal infections, using radioactively labeled antibodies recognizing the cryptococcal capsule, reduced fungal burden and prolonged survival of mice infected with Cryptococcus neoformans. Here, we investigate effects of RIT on bystander mammalian cells. Methods: Heat-killed C. neoformans bound to anti-capsular antibodies, unlabeled or labeled with beta emitter Rhenium-188 (16.9 h half-life), or alpha emitter Bismuth-213 (46 min half-life) was incubated with macrophage-like J774.16 cells or epithelial-like Chinese hamster ovary (CHO) cells. Lactate dehydrogenase activity, crystal violet uptake, reduction of tetrazolium dye XTT, and nitric oxide (NO) production tested cell membrane integrity, viability, replication, and effector function. Results: The J774.16 and CHO cells maintained their membrane integrity, viability and metabolic activity, and were able to replicate and to produce NO following exposure to radiolabeled C. neoformans. Conclusions: These findings show that RIT of C. neoformans is a selective and safe treatment confirming our previous observations on the absence of pathological changes in the lungs and brains of the RIT-treated mice with C. neoformans infection.
JRC Directorate:Nuclear Safety and Security

Files in This Item:
There are no files associated with this item.


Items in repository are protected by copyright, with all rights reserved, unless otherwise indicated.